DoxyPEP Cuts STIs in At-Risk Groups
Doxycycline postexposure prophylaxis (doxyPEP) has the potential to substantially reduce real-world population-level incidence of sexually transmitted infections (STIs), a study in JAMA Internal Medicine suggested. This conclusion was reached by Stephanie …